CELLIBRIUM BIOSCIENCES Trademark

Trademark Overview


On Friday, June 25, 2021, a trademark application was filed for CELLIBRIUM BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the CELLIBRIUM BIOSCIENCES trademark a serial number of 90795404. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, April 30, 2024. This trademark is owned by Cellibrium Biosciences, Inc.. The CELLIBRIUM BIOSCIENCES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, B cell therapies for the treatment of neuroinflammation and immune dysregulation; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for the treatment of autoimmune diseases and traumatic brain injuries

Pharmaceutical research and development; Research and development services in the field of cell therapy
cellibrium biosciences

General Information


Serial Number90795404
Word MarkCELLIBRIUM BIOSCIENCES
Filing DateFriday, June 25, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, April 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, B cell therapies for the treatment of neuroinflammation and immune dysregulation; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for the treatment of autoimmune diseases and traumatic brain injuries
NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesPharmaceutical research and development; Research and development services in the field of cell therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 9, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellibrium Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEast Walpole, MA 02032

Party NameCellibrium Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDedham, MA 02026

Trademark Events


Event DateEvent Description
Tuesday, June 29, 2021NEW APPLICATION ENTERED
Thursday, September 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 17, 2022ASSIGNED TO EXAMINER
Friday, March 18, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, March 18, 2022EXAMINERS AMENDMENT E-MAILED
Friday, March 18, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 18, 2022EXAMINER'S AMENDMENT ENTERED
Friday, March 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 28, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 28, 2022SOU EXTENSION 1 FILED
Monday, November 28, 2022SOU EXTENSION 1 GRANTED
Wednesday, November 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 6, 2023SOU EXTENSION 2 FILED
Tuesday, June 6, 2023SOU EXTENSION 2 GRANTED
Friday, June 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, November 26, 2023SOU TEAS EXTENSION RECEIVED
Sunday, November 26, 2023SOU EXTENSION 3 FILED
Sunday, November 26, 2023SOU EXTENSION 3 GRANTED
Tuesday, November 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024SOU EXTENSION 4 GRANTED
Tuesday, April 30, 2024SOU EXTENSION 4 FILED
Wednesday, May 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2024SOU TEAS EXTENSION RECEIVED